Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Deloitte
Boehringer Ingelheim
Citi
Mallinckrodt
Fuji
Fish and Richardson
Moodys
Baxter

Generated: July 16, 2018

DrugPatentWatch Database Preview

Ferric pyrophosphate citrate - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for ferric pyrophosphate citrate and what is the scope of ferric pyrophosphate citrate freedom to operate?

Ferric pyrophosphate citrate
is the generic ingredient in one branded drug marketed by Rockwell Medical Inc and is included in two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Ferric pyrophosphate citrate has eleven patent family members in ten countries.

There are sixteen drug master file entries for ferric pyrophosphate citrate. Two suppliers are listed for this compound.
Summary for ferric pyrophosphate citrate
Pharmacology for ferric pyrophosphate citrate
Synonyms for ferric pyrophosphate citrate
1275612-31-1
1802359-96-1
CHEMBL3833317
D10933
Ferric pyrophosphate citrate (USAN)
Ferric pyrophosphate citrate [USAN]
H-61
H61
Iron, citrate diphosphate sulfate sodium complexes
SFP, H61
Tetraferric nonahydrogen citrate pyrophosphate
Triferic (TN)
UBY79OCO9G
UNII-UBY79OCO9G

US Patents and Regulatory Information for ferric pyrophosphate citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rockwell Medical Inc TRIFERIC ferric pyrophosphate citrate FOR SOLUTION;INTRAVENOUS 208551-001 Apr 25, 2016 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Rockwell Medical Inc TRIFERIC ferric pyrophosphate citrate SOLUTION;IV (INFUSION) 206317-002 Sep 4, 2015 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Rockwell Medical Inc TRIFERIC ferric pyrophosphate citrate SOLUTION;IV (INFUSION) 206317-001 Jan 23, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for ferric pyrophosphate citrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Rockwell Medical Inc TRIFERIC ferric pyrophosphate citrate SOLUTION;IV (INFUSION) 206317-001 Jan 23, 2015 ➤ Try a Free Trial ➤ Try a Free Trial
Rockwell Medical Inc TRIFERIC ferric pyrophosphate citrate SOLUTION;IV (INFUSION) 206317-001 Jan 23, 2015 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Farmers Insurance
Baxter
Julphar
Johnson and Johnson
Healthtrust
Argus Health
Fish and Richardson
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.